Form D Explorer
Cadrenal Therapeutics, Inc. · CIK 1937993

Report a data issueCitable research briefCompare issuerPrivate research collection

Cadrenal Therapeutics, Inc.

CIK 1937993 · Corporation · Inc. DELAWARE · PONTE VEDRA, Florida · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported offering amount was $7,923,235 in the Apr 6, 2026 filing and $8,843,849 in the Jul 15, 2026 filing. The two records may concern different offerings. All 3 stored filings from Dec 31, 2025 to Jul 15, 2026 are original notices.

Filings
3
Original notices
3
Amendments
0
Activity
Dec 31, 2025
through Jul 15, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldApr 6, 2026 · DJul 15, 2026 · DLater minus earlier
Reported offering amount$7,923,235$8,843,849$920,614
Reported amount sold$7,923,235$8,843,849$920,614
Reported investor count—1—
Reported minimum investment$0$0$0

Earlier SEC source: 0001213900-26-040457 · Later SEC source: 0001213900-26-078373

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Jul 15, 2026

Reported offering amount
$8,843,849
Reported exemptions
Rule 506(b)
Reported amount sold
$8,843,849

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Shared EDGAR submitting account

These filings share an external submitting CIK in their accession numbers. The account may belong to a filing agent. How EDGAR assigns accession numbers.

Form D filings (3)